| 标题 |
AGR, LMR and SIRI are the optimal combinations for risk stratification in advanced patients with non-small cell lung cancer following immune checkpoint blockers |
| 网址 | |
| DOI | |
| 其它 |
期刊:International immunopharmacology 作者:Zhou Y; Liu X; Wu B; Li J; Yi Z; et al 出版日期:2025/03/06 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)